Loading clinical trials...
Loading clinical trials...
Phase-1, Randomized, Single-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD5055 Following Single and Multiple Oral Doses in Japanese and Chinese Healthy Volunteers.
Conditions
Interventions
AZD5055
Placebo
Locations
1
United States
Research Site
Glendale, California, United States
Start Date
July 27, 2023
Primary Completion Date
December 4, 2023
Completion Date
December 4, 2023
Last Updated
December 8, 2023
NCT07310901
NCT06342713
NCT07471204
NCT07401472
NCT07412353
NCT07231497
Lead Sponsor
AstraZeneca
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions